• 1
    Mayer AR, Chambers S, Graves E, Holm C, Tseng PC, Nelson BE, et al. Ovarian cancer staging: does it require a gynecologic oncologist? Gynecol Oncol 1992;47:2237.
  • 2
    Zanetta G, Rota S, Chiari S, Bonazzi C, Bratina G, Torri V, et al. The accuracy of staging: an important prognostic determinator in stage I ovarian carcinoma. Ann Oncol 1998;9:1097101.
  • 3
    Trimbos JB, Vergote I, Bolis G, Vermoken JB, Mangioni C, Madronal C, et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organistaion for Research and Treatment of Cancer––Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 2003;95:11325.
  • 4
    Onda T, Yoshikawa H, Yasugi T, Mishima M, Nakagawa S, Yamada M, et al. Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenectomy have similar survival to Stage I/II patients and superior survival to other Stage III patients. Cancer 1998;83:155560.
  • 5
    Kanazawa K, Suzuki T, Tokashiki M. The validity and significance of substage IIIC by node involvement in epithelial ovarian cancer: impact of nodal metastasis on patient survival. Gynecol Oncol 1999;73:23741.
  • 6
    Chan J, Fuh K, Shin J, Cheung M, Powell C, Chen LM, et al. The treatment and outcome of early-stage ovarian cancer: have we made any progress? Br J Cancer 2008;98:11916.
  • 7
    Pecorelli S, Benedet JL, Creasman WT, Shepherd JH. FIGO staging of gynecologic cancer. 1994–1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet 1999;65:2439.
  • 8
    International Collaborative Ovarian Neoplasm (ICON1) Collaborators. International Collaborative Ovarian Neoplasm Trial 1: a randomised trial of adjuvant chemotherapy in women with early-stage ovarian cancer. J Natl Cancer Inst 2003;95:12532.
  • 9
    Morice P, Joulie F, Camatte S, Atallah D, Rouzier R, Pautier P, et al. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg 2003;197:198205.
  • 10
    Maggioni A, Panici PB, Dell’Anna T, Landoni F, Lissoni A, Pellegrino A, et al. Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer 2006;95:699704.
  • 11
    Querleu D, LeBlanc E, Castelain B. Laparoscopic pelvic lymphadenectomy in the staging of early carcinoma of the cervix. Am J Obstet Gynecol 1991;164:57981.
  • 12
    Spirtos NM, Schlaerth JB, Spirtos TW, Schlaerth AC, Indman PD, Kimball RE. Laparoscopic bilateral pelvic and paraortic lymph node sampling: an evolving technique. Am J Obstet Gynecol 1995;173:10511.
  • 13
    Su TH, Wang KG, Yang YC, Hong BK, Huang SH. Laparoscopic para-aortic lymph node sampling in the staging of invasive cervical carcinoma: including a comparative study of 21 laparotomy cases. Int J Gynaecol Obstet 1995;49:3118.
  • 14
    Chu KK, Chang SD, Chen FP, Soong YK. Laparoscopic surgical staging in cervical cancer—preliminary experience among Chinese. Gynecol Oncol 1997;64:4953.
  • 15
    Possover M, Krause N, Plaul K, Kühne-Heid R, Schneider A. Laparoscopic para-aortic and pelvic lymphadenectomy: experience with 150 patients and review of literature. Gynecol Oncol 1998;71:1928.
  • 16
    Viduarreta J, Bemúdez A, di Paola G, Sardi J. Laparoscopic staging in locally advanced cervical carcinoma: a new possible philosophy? Gynecol Oncol 1999;75:36671.
  • 17
    Dottino PR, Tobias DH, Beddoe A, Golden AL, Cohen CJ. Laparoscopic lymphadenectomy for gynecologic malignancies. Gynecol Oncol 1999;73:3838.
  • 18
    Querleu D, Dargent D, Ansquer Y, Leblanc E, Narducci F. Extraperitoneal endosurgical aortic and common iliac dissection in the staging of bulky or advanced cervical carcinomas. Cancer 2000;88:188391.
  • 19
    Altgassen C, Possover M, Krause N, Plaul K, Michels W, Schneider A. Establishing a new technique of laparoscopic pelvic and para-aortic lymphadenectomy. Obstet Gynecol 2000;95:34852.
  • 20
    Scribner DR Jr, Walker JL, Johnson GA, McMeekin SD, Gold MA, Mannel RS. Laparoscopic pelvic and paraaortic lymph node dissection: analysis of the first 100 cases. Gynecol Oncol 2001;82:498503.
  • 21
    Schlaerth JB, Spirtos NM, Carson LF, Boike G, Adamec T, Stonebraker B. Laparoscopic retroperitoneal lymphadenectomy followed by immediate laparotomy in women with cervical cancer: a gynecologic oncology group study. Gynecol Oncol 2002;85:818.
  • 22
    Vergote I, Amant F, Berteloot P, Van Gramberen M. Laparoscopic lower para-aortic staging lymphadenectomy in stage IB2, II and III cervical cancer. Int J Gynecol Cancer 2002;12:226.
  • 23
    Spirtos NM, Eisekop SM, Boike G, Schlaerth JB, Cappellari JO. Laparoscopic staging in patients with incompletely staged cancers of the uterus, ovary, fallopian tube, and primary peritoneum: a Gynecologic Oncology Group (GOG) study. Am J Obstet Gynecol 2005;193:16459.
  • 24
    Abu-Rustum NR, Alektiar K, Iasonos A, Lev G, Sonoda Y, Aghajanian C, et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12 year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol 2006;103:7148.
  • 25
    The International Collaborative Ovarian Neoplasm (ICON) Group. Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial. Lancet 2002;360:50515.
  • 26
    Ilvan S, Ramazanoglu R, Akyildiz EU, Calay Z, Bese T, Oruc N. The accuracy of frozen section (intraoperative consultation) in the diagnosis of ovarian masses. Gynecol Oncol 2005;95:3959.
  • 27
    Maheshwari A, Gupta S, Kane S, Kulkarni Y, Goyal BK, Tongaonkar HB. Accuracy of intraoperative frozen section in the diagnosis of ovarian neoplasms: Experience at a tertiary oncology center. World J Surg Oncol 2006;4:12. Doi:DOI: 10.1186/1477-7819-4-12.
  • 28
    Naik R, Cross P, Lopes A, Godfrey K, Hatem MH. “True” versus “apparent” stage I epithelial ovarian cancer: value of frozen section analysis. Int J Gynecol Cancer 2006;16 (Suppl 1):416.
  • 29
    Vergote I, De Brabanter J, Fyles A, Bertelsen K, Einhorn N, Sevelda P, et al. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 2001;357:17682.
  • 30
    Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 2000;31:53957.
  • 31
    Camatte S, Morice P, Thoury A, Fourchotte V, Pautier P, Lhomme C, et al. Impact of surgical staging in patients with macroscopic “stage I” ovarian borderline tumours: analysis of a continuous series of 101 cases. Eur J Cancer 2004;40:18429.
  • 32
    Desfeux P, Camatte S, Chatellier G, Blanc B, Querleu D, Lecuru L, et al. Impact of surgical approach on the management of macroscopic early ovarian borderline tumors. Gynecol Oncol 2005;98:3905.
  • 33
    Cadron I, Leunen K, Van Gorp T, Aman Ft, Neven P, Vergote I. Management of borderline ovarian neoplasms. J Clin Onc 2007;25:292837.
  • 34
    Tozzi R, Kohler C, Ferrara A, Schneider A. Laparoscopic treatment of early ovarian cancer: surgical and survival outcomes. Gynecol Oncol 2004;93:199203.
  • 35
    Querleu D, Papageorgiou T, Lambaudie E, Sonoda Y, Narducci F, Leblanc E. Laparoscopic staging of borderline ovarian tumours: results of 30 cases initially presumed as stage Ia borderline ovarian tumours. Br J Obstet Gynecol 2003;110:2014.
  • 36
    International Collaborative Ovarian Neoplasm 1 (ICON1) and European Organisation for Research and Treatment of Cancer Collaborators-Adjuvant ChemoTherapy In Ovarian Neoplasm (EORTC-ACTION). International Collaborative Ovarian Neoplasm Trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 2003;95:10512.
  • 37
    Chan JK, Munro EG, Cheung MK, Husain A, Teng NN, Berek JS, et al. Association of lymphadenectomy and survival in stage 1 ovarian cancer patients. Obstet Gynecol 2007;109:129.
  • 38
    Park JY, Kim DY, Suh DS, Kim JH, Kim YT, Nam JH. Comparison of laparoscopy and laparotomy in surgical staging of early-stage ovarian and fallopian tubal cancer. Ann Surg Oncol 2008;15:20129.
  • 39
    Medeiros LRF, Rosa DD, Bozzetti MC, Rosa MINES, Edelwiess MI, Stein AT, et al. Laparoscopy versus laparotomy for FIGO Stage I ovarian cancer (Review). Cochrane Database of Systematic Reviews 2008;4:134 []. Accessed 30 April 2009.
  • 40
    Beesley V, Janda M, Eakin E, Obermair A, Battistutta D. Lymphedema after gynecological cancer treatment: prevalence, correlates and supportive care needs. Cancer 2007;109:260714.
  • 41
    Ryan M, Staintin MC, Slaytor EK, Jaconelli C, Watts S, Mackenzie P. Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer. Aust N Z J Obstet Gynaecol 2003;43:14852.